Am J Perinatol
DOI: 10.1055/a-2515-2673
Original Article

The Dose-Dependent Effect of Obesity on Adverse Maternal and Neonatal Outcomes in a Hispanic Population

1   Department of Obstetrics and Gynecology, University of Texas Southwestern Medical Center, Dallas, Texas
,
Elise A. Rosenthal
1   Department of Obstetrics and Gynecology, University of Texas Southwestern Medical Center, Dallas, Texas
,
1   Department of Obstetrics and Gynecology, University of Texas Southwestern Medical Center, Dallas, Texas
,
F. Gary Cunningham
1   Department of Obstetrics and Gynecology, University of Texas Southwestern Medical Center, Dallas, Texas
› Author Affiliations
Funding None.

Abstract

Objective This study aimed to evaluate the frequency of adverse maternal and neonatal outcomes associated with maternal obesity in a Hispanic population. We hypothesized that obesity confers a dose-dependent risk associated with these outcomes.

Study Design This was a retrospective cohort study of singleton pregnancies delivered between 24 and 42 weeks gestation at an urban county hospital between 2013 and 2021. Body mass index (BMI) at the first prenatal visit was used as a proxy for prepregnancy weight. Patients were excluded if their first-trimester BMI was not available. Trends in adverse outcomes across increasing obesity classes were assessed.

Results During the study period, 58,497 patients delivered a singleton infant, of which 12,365 (21.1%), 5,429 (9.3%), and 3,482 (6.0%) were in class I, II, and III obesity, respectively. Compared with nonobese patients, obese patients were more likely to be younger and nulliparous with a higher incidence of hypertension and pregestational diabetes. Higher BMI was associated with a significant dose-dependent increase in cesarean delivery (27% for nonobese, 34% for class I, 39% for class II, and 46% for class III obesity); severe preeclampsia (8% in nonobese and 19% for class III obesity); and gestational diabetes (5% in nonobese and 15% in class III obesity). There were significant trends in increasing morbidity for infants born to patients with correspondingly higher obesity classes. Some of these adverse outcomes included respiratory distress syndrome, neonatal intensive care unit admission, fetal anomalies, and sepsis (all p < 0.001).

Conclusion Increasing body mass index is associated with a significant dose-dependent increase in multiple adverse perinatal outcomes in a Hispanic population. Associated adverse maternal outcomes include severe preeclampsia, gestational diabetes, and cesarean delivery. Infants born to patients with correspondingly higher BMI class have significantly increased associated morbidity. Often, only higher BMI classes are significantly associated with these adverse outcomes.

Key Points

  • As BMI increases, pregnant patients are more likely to experience adverse maternal and neonatal outcomes.

  • Many adverse pregnancy outcomes are associated only with a BMI greater than 40 kg/m2.

  • Obesity is associated with cesarean delivery, likely due to an increase in labor dystocia.

Note

This study was presented at “The 44th Annual Pregnancy Meeting,” Society for Maternal-Fetal Medicine, National Harbor, Maryland, February 10 to 14, 2024.




Publication History

Received: 11 May 2024

Accepted: 12 January 2025

Accepted Manuscript online:
14 January 2025

Article published online:
12 February 2025

© 2025. Thieme. All rights reserved.

Thieme Medical Publishers, Inc.
333 Seventh Avenue, 18th Floor, New York, NY 10001, USA

 
  • References

  • 1 Kislal S, Shook LL, Edlow AG. Perinatal exposure to maternal obesity: lasting cardiometabolic impact on offspring. Prenat Diagn 2020; 40 (09) 1109-1125
  • 2 Pantham P, Aye IL, Powell TL. Inflammation in maternal obesity and gestational diabetes mellitus. Placenta 2015; 36 (07) 709-715
  • 3 Marshall NE, Spong CY. Obesity, pregnancy complications, and birth outcomes. Semin Reprod Med 2012; 30 (06) 465-471
  • 4 Crane JM, Murphy P, Burrage L, Hutchens D. Maternal and perinatal outcomes of extreme obesity in pregnancy. J Obstet Gynaecol Can 2013; 35 (07) 606-611
  • 5 Platner MH, Ackerman CM, Howland RE. et al. Severe maternal morbidity and mortality during delivery hospitalization of class I, II, III, and super obese women. Am J Obstet Gynecol MFM 2021; 3 (05) 100420
  • 6 Castaneda C, Marsden K, Maxwell T. et al. Prevalence of maternal obesity at delivery and association with maternal and neonatal outcomes. J Matern Fetal Neonatal Med 2022; 35 (25) 8544-8551
  • 7 U.S. Department of Health & Human Services. “Defining Adult Overweight & Obesity.” Center for Disease Control and Prevention. Accessed Jun 3, 2022 at: https://www.cdc.gov/obesity/basics/adult-defining.html
  • 8 Methods for estimating the due date. Committee opinion no. 700.American College of Obstetricians and Gynecologists. Obstet Gynecol 2017; 129: e150-e154
  • 9 R Core Team. R: A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria. Accessed 2022 at: https://www.R-project.org/
  • 10 El-Chaar D, Finkelstein SA, Tu X. et al. The impact of increasing obesity class on obstetrical outcomes. J Obstet Gynaecol Can 2013; 35 (03) 224-233
  • 11 Durst JK, Tuuli MG, Stout MJ, Macones GA, Cahill AG. Degree of obesity at delivery and risk of preeclampsia with severe features. Am J Obstet Gynecol 2016; 214 (05) 651.e1-651.e5
  • 12 Neal K, Ullah S, Glastras SJ. Obesity class impacts adverse maternal and neonatal outcomes independent of diabetes. Front Endocrinol (Lausanne) 2022; 13: 832678
  • 13 Lynch CM, Sexton DJ, Hession M, Morrison JJ. Obesity and mode of delivery in primigravid and multigravid women. Am J Perinatol 2008; 25 (03) 163-167
  • 14 Blomberg M. Maternal obesity, mode of delivery, and neonatal outcome. Obstet Gynecol 2013; 122 (01) 50-55
  • 15 Bebeau KA, Edenfield AL, Hill A, Van Buren E, Finneran MM, Meglin MF. Impact of pre-pregnancy obesity on cesarean delivery rates in nulliparous pregnant people undergoing induction of labor. J Matern Fetal Neonatal Med 2022; 35 (25) 9934-9939
  • 16 Paidas Teefey C, Reforma L, Koelper NC. et al. Risk factors associated with cesarean delivery after induction of labor in women with class III obesity. Obstet Gynecol 2020; 135 (03) 542-549
  • 17 Polic A, Curry TL, Louis JM. The impact of obesity on the management and outcomes of postpartum hemorrhage. Am J Perinatol 2022; 39 (06) 652-657
  • 18 Lean SC, Derricott H, Jones RL, Heazell AEP. Advanced maternal age and adverse pregnancy outcomes: a systematic review and meta-analysis. PLoS One 2017; 12 (10) e0186287
  • 19 Suk D, Kwak T, Khawar N. et al. Increasing maternal body mass index during pregnancy increases neonatal intensive care unit admission in near and full-term infants. J Matern Fetal Neonatal Med 2016; 29 (20) 3249-3253
  • 20 Hales CM, Carroll MD, Fryar CD, Ogden CL. Prevalence of obesity and severe obesity among adults: United States, 2017-2018. NCHS Data Brief 2020; (360) 1-8
  • 21 Voerman E, Santos S, Inskip H. et al; LifeCycle Project-Maternal Obesity and Childhood Outcomes Study Group. Association of gestational weight gain with adverse maternal and infant outcomes. JAMA 2019; 321 (17) 1702-1715
  • 22 Class QA. Obesity and the increasing odds of cesarean delivery. J Psychosom Obstet Gynaecol 2022; 43 (03) 244-250
  • 23 Brocato B, Lewis D, Mulekar M, Baker S. Obesity's impact on intrapartum electronic fetal monitoring. J Matern Fetal Neonatal Med 2019; 32 (01) 92-94
  • 24 Conner SN, Verticchio JC, Tuuli MG, Odibo AO, Macones GA, Cahill AG. Maternal obesity and risk of postcesarean wound complications. Am J Perinatol 2014; 31 (04) 299-304
  • 25 Catalano PM, Shankar K. Obesity and pregnancy: mechanisms of short term and long term adverse consequences for mother and child. BMJ 2017; 356: j1
  • 26 Challier JC, Basu S, Bintein T. et al. Obesity in pregnancy stimulates macrophage accumulation and inflammation in the placenta. Placenta 2008; 29 (03) 274-281
  • 27 Salihu HM, Luke S, Alio AP, Deutsch A, Marty PJ. The impact of obesity on spontaneous and medically indicated preterm birth among adolescent mothers. Arch Gynecol Obstet 2010; 282 (02) 127-134